Charles Schwab’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.67M | Buy |
216,500
+32,645
| +18% | +$238K | ﹤0.01% | 2763 |
|
|
2025
Q4 | $1.13M | Sell |
183,855
-25,601
| -12% | -$276K | ﹤0.01% | 2888 |
|
|
2025
Q3 | $3.86M | Buy |
209,456
+19,379
| +10% | +$311K | ﹤0.01% | 2540 |
|
|
2025
Q2 | $2.47M | Sell |
190,077
-4,552
| -2% | -$53.8K | ﹤0.01% | 2603 |
|
|
2025
Q1 | $2.06M | Sell |
194,629
-13,173
| -6% | -$209K | ﹤0.01% | 2611 |
|
|
2024
Q4 | $3.53M | Buy |
207,802
+10,180
| +5% | +$192K | ﹤0.01% | 2498 |
|
|
2024
Q3 | $4.59M | Buy |
197,622
+3,224
| +2% | +$69K | ﹤0.01% | 2418 |
|
|
2024
Q2 | $4.73M | Buy |
194,398
+3,632
| +2% | +$110K | ﹤0.01% | 2382 |
|
|
2024
Q1 | $6.44M | Buy |
190,766
+4,456
| +2% | +$158K | ﹤0.01% | 2193 |
|
|
2023
Q4 | $5.87M | Buy |
186,310
+2,369
| +1% | +$56.3K | ﹤0.01% | 2236 |
|
|
2023
Q3 | $4.7M | Buy |
183,941
+5,435
| +3% | +$167K | ﹤0.01% | 2290 |
|
|
2023
Q2 | $5.12M | Sell |
178,506
-870
| -0.5% | -$23.7K | ﹤0.01% | 2230 |
|
|
2023
Q1 | $4.3M | Buy |
179,376
+825
| +0.5% | +$14.8K | ﹤0.01% | 2278 |
|
|
2022
Q4 | $3.03M | Buy |
178,551
+7,727
| +5% | +$135K | ﹤0.01% | 2434 |
|
|
2022
Q3 | $2.53M | Buy |
170,824
+14,566
| +9% | +$244K | ﹤0.01% | 2518 |
|
|
2022
Q2 | $2.46M | Buy |
156,258
+1,707
| +1% | +$33.5K | ﹤0.01% | 2500 |
|
|
2022
Q1 | $4.17M | Buy |
154,551
+3,704
| +2% | +$94.5K | ﹤0.01% | 2362 |
|
|
2021
Q4 | $5.58M | Buy |
150,847
+1,287
| +0.9% | +$52.4K | ﹤0.01% | 2298 |
|
|
2021
Q3 | $7.15M | Buy |
149,560
+4,939
| +3% | +$221K | ﹤0.01% | 2204 |
|
|
2021
Q2 | $4.89M | Buy |
144,621
+6,095
| +4% | +$206K | ﹤0.01% | 2367 |
|
|
2021
Q1 | $5.72M | Buy |
138,526
+2,696
| +2% | +$161K | ﹤0.01% | 2232 |
|
|
2020
Q4 | $5.89M | Buy |
135,830
+18,788
| +16% | +$1.27M | ﹤0.01% | 2140 |
|
|
2020
Q3 | $5.02M | Buy |
117,042
+83,449
| +248% | +$4.14M | ﹤0.01% | 2055 |
|
|
2020
Q2 | $1.57M | Buy |
+33,593
| New | +$1.16M | ﹤0.01% | 2499 |
|
Other funds holding ARCT
AIM
NAMA
VCM
VPM
